Enhanced Human Tissue Microdialysis Using Hydroxypropyl-ß-Cyclodextrin as Molecular Carrier

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  May, Marcus ^a   Batkai, Sandor ^a   Zoerner, Alexander A ^a   Tsikas, Dimitrios ^a   Jordan, Jens ^a   Engeli, Stefan ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; ALCOHOL; ANANDAMIDE; GLUCOSE; GLYCEROL; LACTIC ACID; MOLECULE TRANSPORT AGENT; PYRUVIC ACID; RINGER SOLUTION; UREA;

ABDOMINAL SUBCUTANEOUS FAT; ADULT; ANALYTIC METHOD; ARTICLE; BLOOD FLOW VELOCITY; DIALYSATE; FEMALE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INTERSTITIAL FLUID; LIPOPHILICITY; MALE; METABOLITE; MICRODIALYSIS; NORMAL HUMAN; TISSUE PERFUSION; ULTRAFILTRATION; VASTUS LATERALIS MUSCLE;

ADIPOSE TISSUE; ADULT; BETA-CYCLODEXTRINS; BLOOD CIRCULATION; ENDOCANNABINOIDS; ETHANOL; FEASIBILITY STUDIES; FEMALE; GLUCOSE; HUMANS; LIPOLYSIS; MALE; MICRODIALYSIS; MUSCLE, SKELETAL;

RODENTIA;

EID: 84875932085     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060628     Document Type: Article

References (38)

1. Goodman JC, Robertson CS, (2009) Microdialysis: Is it ready for prime time? Current Opinion in Critical Care 15: 110-117.
2. Groth L, (1996) Cutaneous microdialysis. Methodology and validation. Acta Dermato-Venereologica 197: 1-61.
3. Abrahamsson P, Aberg AM, Johansson G, Winso O, Waldenstrom A, et al. (2011) Detection of myocardial ischaemia using surface microdialysis on the beating heart. Clinical Physiology and Functional Imaging 31: 175-181.
4. Keller AK, Jorgensen TM, Olsen LH, Stolle LB, (2008) Early detection of renal ischemia by in situ microdialysis: An experimental study. The Journal of Urology 179: 371-375.
5. Chaurasia CS, Muller M, Bashaw ED, Benfeldt E, Bolinder J, et al. (2007) AAPS-FDA workshop white paper: Microdialysis principles, application, and regulatory perspectives. Journal of Clinical Pharmacology 47: 589-603.
6. Herkenne C, Alberti I, Naik A, Kalia YN, Mathy FX, et al. (2008) In vivo methods for the assessment of topical drug bioavailability. Pharmaceutical Research 25: 87-103.
7. Li Y, Peris J, Zhong L, Derendorf H, (2006) Microdialysis as a tool in local pharmacodynamics. The AAPS Journal 8: E222-35.
8. Stella VJ, He Q, (2008) Cyclodextrins. Toxicologic Pathology 36: 30-42.
9. FDA (2001) Agency response letter GRAS notice no. GRN 000074. Available: http://www.cfsan.fda.gov/rdb/opa-g074.html. Accessed 15 October 2012.
10. Sun L, Stenken JA, (2003) Improving microdialysis extraction efficiency of lipophilic eicosanoids. Journal of Pharmaceutical and Biomedical Analysis 33: 1059-1071.
11. Sun L, Stenken JA, (2007) The effect of beta-cyclodextrin on liquid chromatography/electrospray-mass spectrometry analysis of hydrophobic drug molecules. Journal of Chromatography A 1161: 261-268.
12. Walker JM, Huang SM, Strangman NM, Tsou K, Sanudo-Pena MC, (1999) Pain modulation by release of the endogenous cannabinoid anandamide. Proceedings of the National Academy of Sciences of the United States of America 96: 12198-12203.
13. Zoerner AA, Batkai S, Suchy MT, Gutzki FM, Engeli S, et al. (2011) Simultaneous UPLC-MS/MS quantification of the endocannabinoids 2-arachidonoyl glycerol (2AG), 1-arachidonoyl glycerol (1AG), and anandamide in human plasma: Minimization of matrix-effects, 2AG/1AG isomerization and degradation by toluene solvent extraction. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 883-884: 161-71.
14. Zoerner AA, Rakers C, Engeli S, Batkai S, May M, et al. (2012) Peripheral endocannabinoid microdialysis: In vitro characterization and proof-of-concept in human subjects. Analytical and Bioanalytical Chemistry 402: 2727-35.
15. Tholance Y, Barcelos G, Quadrio I, Renaud B, Dailler F, et al. (2010) Analytical validation of microdialysis analyzer for monitoring glucose, lactate and pyruvate in cerebral microdialysates. Clinica Chimica Acta 412: 647-54.
16. Magkos F, Sidossis LS, (2005) Methodological approaches to the study of metabolism across individual tissues in man. Current Opinion in Clinical Nutrition and Metabolic Care 8: 501-510.
17. Ekberg NR, Wisniewski N, Brismar K, Ungerstedt U, (2005) Measurement of glucose and metabolites in subcutaneous adipose tissue during hyperglycemia with microdialysis at various perfusion flow rates. Clinica Chimica Acta 359: 53-64.
18. Henriksson J, (1999) Microdialysis of skeletal muscle at rest. Proceedings of the Nutrition Society 58: 919-923.
19. Homola A, Zoremba N, Slais K, Kuhlen R, Sykova E, (2006) Changes in diffusion parameters, energy-related metabolites and glutamate in the rat cortex after transient hypoxia/ischemia. Neuroscience Letters 404: 137-142.
20. Fellander G, Linde B, Bolinder J, (1996) Evaluation of the microdialysis ethanol technique for monitoring of subcutaneous adipose tissue blood flow in humans. International Journal of Obesity and Related Metabolic Disorders 20: 220-226.
21. Farnebo S, Zettersten EK, Samuelsson A, Tesselaar E, Sjoberg F, (2011) Assessment of blood flow changes in human skin by microdialysis urea clearance. Microcirculation 18: 198-204.
22. Adams F, Jordan J, Schaller K, Luft FC, Boschmann M, (2005) Blood flow in subcutaneous adipose tissue depends on skin-fold thickness. Hormone and Metabolic Research 37: 68-73.
23. Plock N, Kloft C, (2005) Microdialysis-theoretical background and recent implementation in applied life-sciences. European Journal of Pharmaceutical Sciences 25: 1-24.
24. Strindberg L, Lonnroth P, (2000) Validation of an endogenous reference technique for the calibration of microdialysis catheters. Scandinavian Journal of Clinical and Laboratory Investigation 60: 205-211.
25. Reinstrup P, Stahl N, Mellergard P, Uski T, Ungerstedt U, et al. (2000) Intracerebral microdialysis in clinical practice: Baseline values for chemical markers during wakefulness, anesthesia, and neurosurgery. Neurosurgery 47: 701-9.
26. de Lange ECM (2013) Recovery and calibration techniques: Toward quantitative microdialysis. In: Müller M, editor. Microdialysis in Drug Development. New York, NY: Springer. 13-34.
27. Clough GF, (2005) Microdialysis of large molecules. The AAPS Journal 7: E686-E692.
28. Hamrin K, Rosdahl H, Ungerstedt U, Henriksson J, (2002) Microdialysis in human skeletal muscle: Effects of adding a colloid to the perfusate. Journal of Applied Physiology 92: 385-393.
29. Hillman J, Aneman O, Anderson C, Sjogren F, Saberg C, et al. (2005) A microdialysis technique for routine measurement of macromolecules in the injured human brain. Neurosurgery 56: 1264-8.
30. Enoksson S, Nordenstrom J, Bolinder J, Arner P, (1995) Influence of local blood flow on glycerol levels in human adipose tissue. International Journal of Obesity and Related Metabolic Disorders 19: 350-354.
31. Pereira CV, Moreira AC, Pereira SP, Machado NG, Carvalho FS, et al. (2009) Investigating drug-induced mitochondrial toxicity: A biosensor to increase drug safety? Current Drug Safety 4: 34-54.
32. Dykens JA, Will Y, (2007) The significance of mitochondrial toxicity testing in drug development. Drug Discovery Today 12: 777-785.
33. Whitaker G, Lunte CE, (2010) Investigation of microdialysis sampling calibration approaches for lipophilic analytes: Doxorubicin. Journal of Pharmaceutical and Biomedical Analysis 53: 490-496.
34. Trickler WJ, Miller DW, (2003) Use of osmotic agents in microdialysis studies to improve the recovery of macromolecules. Journal of Pharmaceutical Sciences 92: 1419-1427.
35. Gould S, Scott RC, (2005) 2-hydroxypropyl-beta-cyclodextrin (HP-beta-CD): A toxicology review. Food and Chemical Toxicology 43: 1451-1459.
36. Maurer MH, Haux D, Unterberg AW, Sakowitz OW, (2008) Proteomics of human cerebral microdialysate: From detection of biomarkers to clinical application. Proteomics- Clinical Applications 2: 437-443.
37. Clausen TS, Kaastrup P, Stallknecht B, (2009) Proinflammatory tissue response and recovery of adipokines during 4 days of subcutaneous large-pore microdialysis. Journal of Pharmacological and Toxicological Methods 60: 281-287.
38. Bodenlenz M, Hofferer C, Magnes C, Schaller-Ammann R, Schaupp L, et al. (2012) Dermal PK/PD of a lipophilic topical drug in psoriatic patients by continuous intradermal membrane-free sampling. European Journal of Pharmaceutics and Biopharmaceutics. 81: 635-641.